MTOR and gastric cancer: In the present study, TAMs-derived CXCL5 was demonstrated to promote 5-FU-resistance and enhance the ability of anti-apoptosis of gastric cancer cells through the activation of PI3K/AKT/mTOR pathway, which has been shown to involve in cancer progression.